Skip to main content

Advertisement

SpringerLink
Log in

Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model

  • Experimental
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study is to compare transarterial chemoembolization (TACE) alone and in combination with other therapies in an animal model. Subcapsular implantation of a solid Morris hepatoma 3924A in the liver was carried out in 50 male ACI rats (day 0). Tumor volume (V1) was measured by MRI (day 13). After laparotomy and retrograde placement of a catheter into the gastroduodenal artery (day 14), the following protocols of the interventional procedure were applied: TACE (mitomycin C + lipiodol) + immunotherapy (group A: TNFα + IL-2, group B: OK-432 + IL-2); TACE + antiangiogenesis therapy (group C: TNP-470, group D: endostatin); TACE alone in group E (control group). Tumor volume (V2) was assessed by MRI and the mean ratio of x (V2/V1) was calculated. Data were analyzed using Dunnett’s t test (comparing therapeutic groups with the control group) and the Student-Newman-Keuls test (comparing significant therapeutic groups). Multivariate analysis showed a significant reduction in the tumor growth rate (P<0.05) in groups B (x=6.53) and C (x=4.01) compared to the mean ratio of the control group E (x=9.14). Significant results were observed in group C (P<0.05) in comparison with the other therapeutic groups. TACE combined with immunotherapy (OK-432) and antiangiogenesis therapy (TNP-470) retards tumor growth compared with TACE alone in an HCC animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cha C, DeMatteo RP, Blumgart LH (2002) Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 35(5 Suppl 2):S130–S137

    Article  Google Scholar 

  2. Tang ZY (1998) Treatment of hepatocellular carcinoma. Digestion 59(5):556–562

    Article  CAS  PubMed  Google Scholar 

  3. Alsowmely AM, Hodgson HJ (2002) Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 16(1):1–15

    Google Scholar 

  4. Durand F, Belghiti J (2002) Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 49(43):47–52

    PubMed  Google Scholar 

  5. Poon RT et al (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235(4):466–486

    Article  PubMed  Google Scholar 

  6. Denys AL et al (2003) Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 13(10):2346–2352

    Article  PubMed  Google Scholar 

  7. Lee JM et al (2004) Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver. Eur Radiol 14(7):1303–1310

    PubMed  Google Scholar 

  8. Buscarini E, Buscarini L (2004) Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol 14(1):31–37

    Article  PubMed  Google Scholar 

  9. Sturm JW et al (2001) Locally ablative therapies of hepatocellular carcinoma. Onkologie 24(Suppl 5):35–45

    Article  Google Scholar 

  10. Achenbach T et al (2002) Chemoembolization for primary liver cancer. Eur J Surg Oncol 28(1):37–41

    Article  CAS  PubMed  Google Scholar 

  11. Llovet JM et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739

    Article  PubMed  Google Scholar 

  12. Vogl TJ et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214(2):349–357

    CAS  PubMed  Google Scholar 

  13. Lin DY, Lin SM, Liaw YF (1997) Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 12(9–10):S319–S328

    CAS  PubMed  Google Scholar 

  14. Yoshida T et al (2001) Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study. J Clin Gastroenterol 32(1):59–65

    Article  CAS  PubMed  Google Scholar 

  15. Mugitani T et al (1998) TNP-470 inhibits collateralization to complement the anti-tumour effect of hepatic artery ligation. Br J Cancer 77(4):638–642

    CAS  PubMed  Google Scholar 

  16. Zheng C, Feng G, Liang H (1998) Bletilla striata as a vascular embolizing agent in interventional treatment of primary hepatic carcinoma. Chin Med J (Engl) 111(12):1060–1063

    CAS  Google Scholar 

  17. Yang R et al (1992) A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 52(3):193–198

    Article  CAS  PubMed  Google Scholar 

  18. Trubenbach J et al (2000) Growth characteristics and imaging properties of the morris hepatoma 3924A in ACI rats: a suitable model for transarterial chemoembolization. Cardiovasc Intervent Radiol 23(3):211–217

    Article  CAS  PubMed  Google Scholar 

  19. Fournier LS et al (2004) Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 14:2125-2133

    PubMed  Google Scholar 

  20. Klein D et al (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14(6):1082–1091

    Article  PubMed  Google Scholar 

  21. Nicolau C et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14(6):1092–1099

    Article  PubMed  Google Scholar 

  22. Koda M et al (2004) Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol 14(6):1100–1108

    Article  PubMed  Google Scholar 

  23. Kwak HS, Lee JM, Kim CS (2004) Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14(3):447–457

    Article  PubMed  Google Scholar 

  24. Carlsson G, Gullberg B, Hafstrom L (1983) Estimation of liver tumor volume using different formulas—an experimental study in rats. J Cancer Res Clin Oncol 105(1):20–23

    Article  CAS  PubMed  Google Scholar 

  25. Choi BI et al (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713

    CAS  PubMed  Google Scholar 

  26. Pacella CM et al (2001) Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219(3):669–678

    CAS  PubMed  Google Scholar 

  27. Koda M et al (2001) Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 92(6):1516–1524

    Article  CAS  PubMed  Google Scholar 

  28. Bloomston M et al (2002) Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 68(9):827–831

    PubMed  Google Scholar 

  29. Qian J et al (2003) Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol 9(1):94–98

    CAS  PubMed  Google Scholar 

  30. Uehara K et al (2002) Systemic administration of liposome-encapsulated OK-432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-gamma-producing hepatic lymphocytes. J Gastroenterol Hepatol 17(1):81–90

    Article  CAS  PubMed  Google Scholar 

  31. Nio Y et al (1999) Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. Br J Cancer 80(5–6):775–785

    Article  CAS  PubMed  Google Scholar 

  32. Oka M et al (1994) Intraarterial combined immunochemotherapy for unresectable hepatocellular carcinoma: preliminary results. Cancer Immunol Immunother 38(3):194–200

    Article  CAS  PubMed  Google Scholar 

  33. Kanai T et al (1994) New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases. Cancer Chemother Pharmacol 33(Suppl):S48–S54

    PubMed  Google Scholar 

  34. Okuno K et al (1996) IL-2 perfusion to the liver augments the hepatic extraction rate of accompanying anticancer drugs. Surg Today 26(8):662–664

    Article  CAS  PubMed  Google Scholar 

  35. Okuno K et al (1999) Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trial. Hepatogastroenterology 46(26):1116–1121

    CAS  PubMed  Google Scholar 

  36. Watanabe D et al (1995) Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits. Oncology 52(1):76–81

    CAS  PubMed  Google Scholar 

  37. Yang R et al (1995) Experimental liver cancer: improved response after hepatic artery ligation and infusion of tumor necrosis factor-alpha and interferon-gamma. Surgery 118(4):768–72 (discussion 772–774)

    CAS  PubMed  Google Scholar 

  38. Westphal JR, Ruiter DJ, De Waal RM (2000) Anti-angiogenic treatment of human cancer: pitfalls and promises. Int J Cancer 86(6):870–873

    CAS  PubMed  Google Scholar 

  39. Keshet E, Ben-Sasson SA (1999) Anticancer drug targets: approaching angiogenesis. J Clin Invest 104(11):1497–1501

    CAS  PubMed  Google Scholar 

  40. Tomanek RJ, Schatteman GC (2000) Angiogenesis: new insights and therapeutic potential. Anat Rec 261(3):126–135

    Article  CAS  PubMed  Google Scholar 

  41. Folkman J (1996) New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A(14):2534–2539

    Article  CAS  PubMed  Google Scholar 

  42. Drixler TA et al (2000) Angiogenesis and surgery: from mice to man. Eur J Surg 166(6):435–446

    Article  CAS  PubMed  Google Scholar 

  43. O’Reilly MS (2002) The combination of antiangiogenic therapy with other modalities. Cancer J 8(Suppl 1):S89–S99

    PubMed  Google Scholar 

  44. Kim YB, Park YN, Park C (2001) Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology 38(2):160–166

    Article  CAS  PubMed  Google Scholar 

  45. Ogawa H et al (2000) Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo. Oncol Rep 7(3):467–472

    CAS  PubMed  Google Scholar 

  46. Figg WD et al (1997) The pharmacokinetics of TNP-470, a new angiogenesis inhibitor. Pharmacotherapy 17(1):91–97

    CAS  PubMed  Google Scholar 

  47. Yanai S et al (1995) Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma. Pharm Res 12(5):653–657

    Article  CAS  PubMed  Google Scholar 

  48. Yanai S et al (1994) Antitumor activity of a medium-chain triglyceride solution of the angiogenesis inhibitor TNP-470 (AGM-1470) when administered via the hepatic artery to rats bearing Walker 256 carcinosarcoma in the liver. J Pharmacol Exp Ther 271(3):1267–1273

    CAS  PubMed  Google Scholar 

  49. Wang X et al (2002) Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol 8(2):253–257

    CAS  PubMed  Google Scholar 

  50. O’Reilly MS et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277–285

    Article  Google Scholar 

  51. Jiang YF, Yang ZH, JQ Hu (2000) Recurrence or metastasis of HCC: predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 6(1):61–65

    PubMed  Google Scholar 

  52. te Velde EA et al (2002) Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model. Br J Surg 89(10):1302–1309

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany

    A. Maataoui, J. Qian, D. Vossoughi, M. F. Khan & T. J. Vogl

  2. Department of Visceral Surgery, Johann Wolfgang Goethe University, Frankfurt/Main, Germany

    E. Oppermann & W. O. Bechstein

Authors
  1. A. Maataoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Vossoughi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. F. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Oppermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. O. Bechstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. J. Vogl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Maataoui.

Additional information

The first two authors contributed equally to this publication.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maataoui, A., Qian, J., Vossoughi, D. et al. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model. Eur Radiol 15, 127–133 (2005). https://doi.org/10.1007/s00330-004-2517-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-004-2517-8

Keywords

Search

Navigation